跳至主要内容
临床试验/CTRI/2021/01/030216
CTRI/2021/01/030216已完成2 期

Clinical evaluation of the effect on oral administration of VILVA ENNAI for the treatment of VALI KANAM.

Dr K Ragavi Sayi Saranya1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2021年5月1日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Decreases the body temperature, cough, vomitting, constipation and other clinical symptoms.

研究概览

简要总结

The study is a single arm clinical trial to evaluate the therapeutic efficacy of VILVA ENNAI for the treatment of VALI KANAM. The trial drug will be administered orally at the dose of 4 ml before the food once a day at morning for a period of 10 days in 56 patients. The trial period of 24 months will be carrying out in Government Siddha Medical College and Hospital, Palayamkottai, Tirunelveli, Tamilnadu.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
3.00 Year(s) 至 12.00 Year(s)(—)
性别
All

入选标准

  • subjects with any of the following symptoms will be included in the study
  • Fever associated with Respiratory symptoms, Urinary tract symptoms and Gastrointestinal symptoms
  • Loss of appetite
  • Vomitting
  • Decreased urine output
  • Dryness of mouth
  • Constipation.

排除标准

  • Children below 3 years and above 12 years
  • Fever due to malignancy, trauma, psychological factors
  • High grade fever
  • Cough with hemoptysis
  • Fever associated with other complications such as HIV, meningitis, Tuberculosis
  • Cardiac diseases
  • Chronic Renal diseases
  • Severe Dehydration.

结局指标

主要结局

Decreases the body temperature, cough, vomitting, constipation and other clinical symptoms.

时间窗: 10 days

次要结局

未报告次要终点

研究者

发起方
Dr K Ragavi Sayi Saranya
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验